Rocket Doctor AI (9390) Stock Price & Analysis
9390 Stock Chart & Stats
- Day’s Range
- EUR 0.27 - EUR 0.28
- 52-Week Range
- EUR 0.27 - EUR 0.55
- Previous Close
- EUR 0.29
- Volume
- 0
- Average Volume (3M)
- 559
- Market Cap
- EUR 28.45M
- Enterprise Value
- EUR 58.25M
- Total Cash (Recent Filing)
- EUR 947.65K
- Total Debt (Recent Filing)
- EUR 1.20M
- Price to Earnings (P/E)
- ―
- Beta
- 0.59
- Next Earnings
- Dec 01, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Rapid Revenue Scaling
Revenue is scaling rapidly from a small base, indicating that Rocket Doctor AI is expanding commercial activity and gaining adoption for its offerings. If this growth persists, a larger revenue base could improve operating leverage and provide greater capacity to fund product development and care delivery.
Virtual Care Platform
The virtual-care model provides a scalable way to connect patients and licensed clinicians without relying solely on in-person delivery. Its digital structure can support broader access and recurring platform activity, while the clinical workflow focus extends the company beyond a single telemedicine use case.
AI-Enabled Clinical Workflows
AI-enabled workflow tools give Rocket Doctor AI a second avenue for expansion alongside direct virtual consultations. Embedding software into clinical processes can deepen the platform’s role with providers and create a more durable technology offering as digital health adoption develops.
Bears Say
Persistent Unprofitability
The company has not yet demonstrated a profitable operating model: losses remain very large relative to revenue, and even gross profit is slightly negative on a trailing basis. Without meaningful margin improvement, future revenue growth may continue to require substantial funding rather than translate into durable earnings.
Sustained Cash Burn
Ongoing negative operating and free cash flow indicate that the business is consuming substantial cash to support operations. Continued burn can restrict investment flexibility and increase reliance on external financing, making financial stability dependent on improving cash conversion over the coming quarters.
Balance Sheet Deterioration
Leverage has risen sharply as equity declined, leaving a materially thinner capital cushion while the company continues to report losses. Higher debt relative to equity reduces financial flexibility, increases the consequences of further operating shortfalls, and may constrain funding choices for growth.
Rocket Doctor AI News
9390 FAQ
What was Rocket Doctor AI’s price range in the past 12 months?
What is Rocket Doctor AI’s market cap?
When is Rocket Doctor AI’s upcoming earnings report date?
How were Rocket Doctor AI’s earnings last quarter?
Is Rocket Doctor AI overvalued?
Does Rocket Doctor AI pay dividends?
What is Rocket Doctor AI’s EPS estimate?
How many shares outstanding does Rocket Doctor AI have?
What happened to Rocket Doctor AI’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Rocket Doctor AI?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Rocket Doctor AI
Rocket Doctor AI Inc., based in Vancouver, Canada, specializes in delivering personalized healthcare information services across the Canadian market. The company develops a mobile application crafted to help users assess their symptoms and effectively manage their health issues, concerns, and ongoing wellness journey. This sophisticated digital health platform also functions as an insightful assessment tool, offering valuable health analytics. Furthermore, Rocket Doctor AI Inc. provides a range of additional solutions, including medical education resources, tools for medical clinics, expert clinical advisory services, and a comprehensive healthcare information hub. Established in 2018, the company was formerly known as Treatment.com AI Inc. and is slated to officially adopt the name Rocket Doctor AI Inc. in August 2025.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Essam Hamza
- Employees
- 3
- Website
- www.treatment.com
- Address
- 800 – 885 West Georgia Street, Vancouver, BC, V6C 3H1, CA
Rocket Doctor AI (9390) Earnings & Revenues
9390 Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 3 | 5 | 14 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 0 | 0 | 12 |








